ATRC vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

ATRC

37.1
AI Score
VS
XRAY Wins

XRAY

43.0
AI Score

Investment Advisor Scores

ATRC

37score
Recommendation
SELL

XRAY

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ATRC XRAY Winner
Revenue 449.30M 2.61B XRAY
Net Income 13.13M 25.00M XRAY
Gross Margin 77.3% 52.1% ATRC
Net Margin 2.9% 1.0% ATRC
Operating Income 14.54M 84.00M XRAY
ROE 2.5% 1.8% ATRC
ROA 1.8% 0.5% ATRC
Total Assets 717.54M 5.19B XRAY
Cash 187.03M 195.00M XRAY
Debt/Equity 0.11 1.46 ATRC
Current Ratio 4.33 1.63 ATRC

Relative Price Performance (Last 90 Days)

ATRC 1M: -1.1% · 3M: +29.4% XRAY 1M: +12.5% · 3M: -17.4%

Current Technical Phase

ATRC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.5 · Price: $56.27

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.3 · Price: $9.57

Fundamentals Snapshot

Metric ATRC XRAY
Market Cap — —
Forward P/E 122.3 7.7
Trailing P/E 186.4 —
Revenue (TTM) — —
Revenue Growth 0.2% -0.1%
Gross Margin 0.8% 0.5%
Operating Margin 0.0% 0.0%
EPS 0.31 -0.61
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.